StockData
BlossomHill Therapeutics, Inc. logo

BlossomHill Therapeutics, Inc. (BLSM) stock

BLSMNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026
$14.41−0.18 (-1.23%)

Close on Nov 19, 2026Market cap $36.73MP/E –Yield –

BlossomHill Therapeutics shares outstanding

Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.

BlossomHill Therapeutics's shares outstanding was 3M at Jun 30, 2026.

Quarterly shares outstanding

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 20263M–
Q2 FY2025Jun 30, 20252M–

More BlossomHill Therapeutics figures

See a number that looks wrong?